Actively Recruiting
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
Led by Boston Children's Hospital · Updated on 2025-07-02
30
Participants Needed
1
Research Sites
407 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study will measure plasma concentrations of bivalirudin in pediatric patients undergoing cardiac catheterization, cardiac surgical procedures utilizing cardiopulmonary bypass (CPB), or extracorporeal support with ECMO, ventricular support devices (VAD) or lung-assist devices (LAD). The aim is to understand the pharmacokinetics of bivalirudin in these settings.
CONDITIONS
Official Title
Pharmacokinetics of Bivalirudin for Pediatric Anticoagulation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patient under 18 years old
- Weight greater than 3 kilograms
- Scheduled to undergo cardiac catheterization, cardiac surgery using cardiopulmonary bypass, or extracorporeal support
- Already planned to receive bivalirudin as part of treatment
You will not qualify if you...
- Age 18 years or older
- Weight less than 3 kilograms
- End-stage kidney failure requiring renal replacement therapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Boston Children's Hospital
Boston, Massachusetts, United States, 02116
Actively Recruiting
Research Team
Z
Zaleski L Zaleski, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here